Baxter International (BAX)

NYSE Health Care Health Care Equipment S&P 500
$25.79
+0.14 (+0.55%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+12.1%
1M+7.9%
3M-7.2%
6M+43.4%
YTD+35.0%
1Y+43.7%
3Y-21.4%
5Y-67.3%

Key statistics

Full financials →
Market cap$13.3B
P/E (TTM)—
EPS (TTM, diluted)$-1.42
P/S1.15
P/B2.05
EV / EBITDA28.3
Revenue (TTM)$11.61B
Revenue growth+5.3%
Net margin-6.2%
ROE-11.1%
Debt / equity1.45
FCF yield12.3%
Dividend yield0.16%
Payout ratio—
Beta (1Y)1.05
Volatility (1Y)42.5%
52-week range$15.73 – $30.00
Avg volume (50D)6.91M

Revenue & net income — last 8 quarters

Statements →
Oct 29, 7:18 AM ET

Baxter Q3 sales rise 5% to $2.98 billion; company raises 2026 outlook

Positive earnings 2.028.01

Baxter reported third-quarter 2026 sales of $2.98 billion, up 5% on both a reported and organic basis, and GAAP diluted EPS of $0.57 versus a loss of $0.09 a year earlier. Adjusted diluted EPS fell 16% to $0.58, and the company raised its full-year 2026 outlook, including adjusted EPS of $2.05 to $2.15. The board also declared a $0.01 quarterly dividend payable January 4, 2027.

  • Q3 sales of approximately $2.98 billion, up 5% reported and organic; U.S. sales up 3% reported, international up 7% reported
  • GAAP diluted EPS of $0.57 versus a loss of $0.09 a year earlier; adjusted diluted EPS of $0.58, down 16% from $0.69, due to a higher effective tax rate
  • Full-year 2026 adjusted EPS outlook raised to $2.05 to $2.15 from $1.95 to $2.15; reported sales growth raised to 4% to 5% from 3% to 4%
  • Quarterly dividend of $0.01 per share, record date November 27, 2026, payable January 4, 2027
Read the filing on SEC.gov ↗
Aug 19, 8:07 AM ET

Baxter names John Rogers CFO effective Oct. 1, 2026; interim CFO Hider to serve

Neutral leadership Written later 5.027.01

Baxter International appointed John Rogers, formerly CFO of Smith+Nephew, as executive vice president and chief financial officer, effective October 1, 2026. Anita Zielinski, interim CFO and chief accounting officer, departs September 15, 2026, and CEO Andrew Hider will serve as interim CFO until Rogers starts. The company also reiterated its full-year 2026 outlook from its July 30, 2026 earnings announcement.

  • Rogers base salary is $925,000, with a target annual bonus of 100% of base salary and a $4,000,000 target annual equity grant value starting with the 2027 grant.
  • Rogers receives a $2,827,629 sign-on bonus, subject to repayment if he leaves within 12 months of his start date, or 50% if he leaves within 12 to 24 months.
  • Andrew Hider serves as interim CFO from September 15, 2026 until October 1, 2026, with no additional compensation for that role.
  • Bernie Heine was named interim chief accounting officer and controller effective September 15, 2026, with a $15,000 monthly payment and a $250,000 grant-date value equity award.
Read the filing on SEC.gov ↗
Aug 18, 5:00 PM ET

Baxter amends credit covenant and raises note tender cap to $600 million

Neutral financing Written later 1.018.01

Baxter entered into Amendment No. 2 to its credit agreement on August 18, 2026, raising the maximum net leverage ratio for five fiscal quarters ending September 30, 2026 through September 30, 2027, and removing Baxter World Trade SRL as a borrower. The same day, the company raised the aggregate purchase price cap on its cash tender offers for certain senior notes from $500 million to $600 million and said it expects to accept $600 million of tendered notes for settlement on August 20, 2026.

  • Amendment No. 2, dated August 18, 2026, raises the maximum net leverage ratio covenant for the five fiscal quarters ending September 30, 2026 through September 30, 2027.
  • The tender offer purchase price cap rose from $500 million to $600 million, excluding accrued interest.
  • Holders who tendered by 5:00 p.m. New York City time on August 17, 2026 and were accepted receive an early tender premium of $30 per $1,000 principal amount, with early settlement on August 20, 2026.
  • Tenders for the 2.539% Senior Notes due 2032 totaled $756,712,000 of $1,550,000,000 outstanding, and the proration factor for that series is 31.37%.
Read the filing on SEC.gov ↗
Aug 4, 5:22 PM ET

Baxter CFO Anita Zielinski to resign effective September 15, 2026, to join another company

Neutral leadership Written later 5.02

Baxter International said its Interim Chief Financial Officer and Chief Accounting Officer and Controller, Anita Zielinski, will resign effective September 15, 2026, to join another company. The company said her decision was not due to any disagreement over operations, policies, practices, financial disclosures or accounting matters.

  • Anita Zielinski notified Baxter of her resignation on July 31, 2026.
  • Her resignation takes effect September 15, 2026.
  • She held the roles of Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller.
  • The filing states the departure was not related to any disagreement with management or the board.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own BAX

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $369.84K0.00% Added

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All BAX congressional trades →
TradedMemberTypeAmount
Oct 31, 2025Lisa McClain MI-09Sell$1,001 – $15,000
Oct 30, 2025Lisa McClain MI-09Buy$1,001 – $15,000
Oct 30, 2025Lisa McClain MI-09Sell$1,001 – $15,000
Sep 25, 2025Lisa McClain MI-09Buy$1,001 – $15,000
Aug 04, 2025Lisa McClain MI-09Sell$1,001 – $15,000
Jul 22, 2025Lisa McClain MI-09Buy$1,001 – $15,000
May 15, 2025Rob Bresnahan PA-08Buy$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Baxter International's SEC XBRL filings. Not investment advice.